The increased use of connected injection devices, or CIDs, yields potential benefits in terms of improved patient care, but human factors engineering (HFE) approaches require adaptation in order to address these devices.
Connected injection devices (CIDs) typically involve an injection device such as an autoinjector with embedded connectivity to an application hosted on a smartphone, with connection to a cloud-based data storage facility. The resulting system might also provide users with web-based added functionality, such as lifestyle advice and the ability to add sensors from additional devices (e.g., pulse oximeters or spirometers).
Connected injection devices include a variety of features, including:
- Remote monitoring of the frequency and success of patient’s injections for healthcare professionals.
- Monitoring the level of remaining medication in pen-injectors.
- Accurate and objective records of the patient’s injections with the date, time, dose, as well as needle depth and injection speed.
- Reminders for injections sent in the form of mobile notifications.
The claimed benefits to patients of CIDs include improved adherence by the use of reminders, improved injection technique, more rapid “onboarding” of new patients and crucially improved health…